Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.

Literature DB >> 15917558

In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.

Yunhua Chen¹, Elizabeth Garber, Qiuqu Zhao, Yigong Ge, Matthew A Wikler, Koné Kaniga, Lisa Saiman.

Abstract

Doripenem 50% inhibitory concentrations (MIC50) and 90% inhibitory concentrations (MIC90) for multidrug-resistant strains of mucoid Pseudomonas aeruginosa (n=200 strains), nonmucoid P. aeruginosa (n=200), and Burkholderia cepacia complex (n=200) isolated from patients with cystic fibrosis were 8 and 32, 8 and 64, and 8 and 32 microg/ml, respectively. Doripenem had somewhat better activity than established antimicrobial agents.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2005 PMID： 15917558 PMCID： PMC1140534 DOI： 10.1128/AAC.49.6.2510-2511.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

9 in total

1. Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens.

Authors: A Watanabe; H Takahashi; T Kikuchi; T Kobayashi; K Gomi; S Fujimura; Y Tokue; T Nukiwa
Journal: Chemotherapy Date: 2000 May-Jun Impact factor: 2.544

2. In vitro antimicrobial activity of doripenem, a new carbapenem.

Authors: Yigong Ge; Matthew A Wikler; Daniel F Sahm; Renée S Blosser-Middleton; James A Karlowsky
Journal: Antimicrob Agents Chemother Date: 2004-04 Impact factor: 5.191

3. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Authors: L Saiman; F Mehar; W W Niu; H C Neu; K J Shaw; G Miller; A Prince
Journal: Clin Infect Dis Date: 1996-09 Impact factor: 9.079

Review 4. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control.

Authors: J J LiPuma
Journal: Curr Opin Pulm Med Date: 1998-11 Impact factor: 3.155

5. In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.

Authors: M Tsuji; Y Ishii; A Ohno; S Miyazaki; K Yamaguchi
Journal: Antimicrob Agents Chemother Date: 1998-01 Impact factor: 5.191

6. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.

Authors: Jeffrey L Blumer; Lisa Saiman; Michael W Konstan; David Melnick
Journal: Chest Date: 2005-10 Impact factor: 9.410

Review 7. Microbiology of airway disease in patients with cystic fibrosis.

Authors: P H Gilligan
Journal: Clin Microbiol Rev Date: 1991-01 Impact factor: 26.132

Review 8. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

Authors: Lisa Saiman; Jane Siegel
Journal: Am J Infect Control Date: 2003-05 Impact factor: 2.918

9. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.

Authors: Shazad Mushtaq; Yigong Ge; David M Livermore
Journal: Antimicrob Agents Chemother Date: 2004-04 Impact factor: 5.191

9 in total

8 in total

1. Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients.

Authors: Sunil Taneja; Pramod Kumar; Vikas Gautam; Ajay Duseja; Virendra Singh; Radha K Dhiman; Yogesh Chawla
Journal: J Clin Exp Hepatol Date: 2016-08-28

2. In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures.

Authors: Aryun Kim; Mary Anne Banevicius; David P Nicolau
Journal: Antimicrob Agents Chemother Date: 2008-05-05 Impact factor: 5.191

Review 3. Cefepime: a reappraisal in an era of increasing antimicrobial resistance.

Authors: Andrea Endimiani; Federico Perez; Robert A Bonomo
Journal: Expert Rev Anti Infect Ther Date: 2008-12 Impact factor: 5.091

4. MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.

Authors: Cédric Bretonnière; Adeline Maitte; Jocelyne Caillon; Gilles Potel; David Boutoille; Cédric Jacqueline; Christophe Guitton
Journal: J Antibiot (Tokyo) Date: 2016-03-30 Impact factor: 2.649